Literature DB >> 9109881

A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations.

B L Miller1, C Ikonte, M Ponton, M Levy, K Boone, A Darby, N Berman, I Mena, J L Cummings.   

Abstract

We evaluated the Lund-Manchester research criteria (LMRC) for frontotemporal dementia (FTD). With single-photon emission CT, we diagnosed 30 patients with FTD. These patients were compared with 30 with a research diagnosis of Alzheimer's disease (AD). We scored every patient on each LMRC item and compared the two groups. A discriminant function showed that loss of personal awareness, hyperorality, stereotyped and perseverative behavior, progressive reduction of speech, and preserved spatial orientation differentiated 100% of FTD and AD subjects. Items relating to affect and physical findings were not different in FTD versus AD. Loss of personal awareness, eating, perseverative behavior, and reduction of speech are the LMRC items that most clearly differentiate FTD from AD.

Entities:  

Mesh:

Year:  1997        PMID: 9109881     DOI: 10.1212/wnl.48.4.937

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  29 in total

Review 1.  Behavioural problems associated with dementia: the role of newer antipsychotics.

Authors:  G Stoppe; C A Brandt; J H Staedt
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

2.  Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.

Authors:  Katherine J Bangen; Jayandra J Himali; Alexa S Beiser; Daniel A Nation; David J Libon; Caroline S Fox; Sudha Seshadri; Philip A Wolf; Ann C McKee; Rhoda Au; Lisa Delano-Wood
Journal:  J Alzheimers Dis       Date:  2016-07-06       Impact factor: 4.472

3.  Alzheimer's disease and frontal variant of frontotemporal dementia-- a very brief battery for cognitive and behavioural distinction.

Authors:  Roberta Perri; Giacomo Koch; Giovanni A Carlesimo; Laura Serra; Lucia Fadda; Patrizio Pasqualetti; Carla Pettenati; Carlo Caltagirone
Journal:  J Neurol       Date:  2005-05-23       Impact factor: 4.849

Review 4.  Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review.

Authors:  Michal Harciarek; Krzysztof Jodzio
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

5.  The Framingham Brain Donation Program: neuropathology along the cognitive continuum.

Authors:  Rhoda Au; Sudha Seshadri; Kristen Knox; Alexa Beiser; Jayandra J Himali; Howard J Cabral; Sanford Auerbach; Robert C Green; Philip A Wolf; Ann C McKee
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

Review 6.  The neuropsychological profile of Alzheimer disease.

Authors:  Sandra Weintraub; Alissa H Wicklund; David P Salmon
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

7.  A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration.

Authors:  Stefan Poljansky; Bernd Ibach; Barbara Hirschberger; Peter Männer; Hans Klünemann; Göran Hajak; Jörg Marienhagen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-01-05       Impact factor: 5.270

Review 8.  Diagnosis of dementia and treatment of Alzheimer's disease. Pharmacologic management of disease progression and cognitive impairment.

Authors:  R van Reekum; M Simard; K Farcnik
Journal:  Can Fam Physician       Date:  1999-04       Impact factor: 3.275

9.  Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.

Authors:  Madhavi Tripathi; Manjari Tripathi; Nishikant Damle; Suman Kushwaha; Abhinav Jaimini; Maria M D'Souza; Rajnish Sharma; Sanjiv Saw; Anupam Mondal
Journal:  Neuroradiol J       Date:  2014-02-24

Review 10.  Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.

Authors:  Conrad C Weihl; Alan Pestronk; Virginia E Kimonis
Journal:  Neuromuscul Disord       Date:  2009-04-19       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.